Friday, 15 September 2017

GSK's three-in-one inhaler gets positive opinion from EU agency

(Reuters) - GlaxoSmithKline said on Friday that a European Medicines Agency (EMA) panel has recommended the company's three-in-one inhaled lung drug.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)